date,title,source
Oct-23-18,Provention Bio Announces Completion of Enrollment of Phase 1b Clinical Trial of PRV-300 in Moderate-to-Severe Ulcerative Colitis,PR Newswire
Nov-05-18,Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease,PR Newswire
Nov-08-18,Provention Bio Reports Third Quarter 2018 Financial Results and Provides Business Update,PR Newswire
Nov-28-18,Provention Bio Joins the C-Path Type 1 Diabetes (T1D) Consortium,PR Newswire
Dec-25-18,"Are Insiders Buying Provention Bio, Inc. (NASDAQ:PRVB) Stock?",Simply Wall St.
Jan-03-19,"Provention Bio Announces Publication in ""Expert Review of Vaccines"" Describing the Scientific Rationale for Developing a Vaccine for Type 1 Diabetes by Targeting Coxsackievirus B",PR Newswire
Jan-28-19,Provention Bio Receives Notice of Allowance from United States Patent and Trademark Office for Patent on Multi-Strain Coxsackievirus B Vaccine for Preventing or Treating Type 1 Diabetes (T1D),PR Newswire
Feb-13-19,Provention Bio To Present at 8th Annual Leerink Partners Global Healthcare Conference,PR Newswire
Mar-12-19,"Provention Bio to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 19, 2019",PR Newswire
Mar-19-19,Provention Bio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update,PR Newswire
Mar-28-19,"Provention Bio Appoints Jeffrey Bluestone, PhD, to Board of Directors",PR Newswire
Apr-02-19,Provention Bio Announces Key Additions to its Senior Management Team,PR Newswire
Apr-09-19,Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes,PR Newswire
Apr-12-19,"Provention Bio, Inc. (PRVB) Shares March Higher, Can It Continue?",Zacks
Apr-24-19,Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease,PR Newswire
May-09-19,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",Benzinga
